News

NextDocs announced it has formed a partnership with Information Services International-Dentsu, Ltd.

The image acquisition and analysis components of R&D and clinical trials can be quite complex...

Switzerland is a country small in size, but big in innovation that has always been an attractive location for clinical trials.

Designing protocols to maintain a trial's validity while enabling seriously ill and informed participants to receive both SOC and investigational products will help to improve patient participation in oncology clinical trials.

ICON announced it has been awarded a project by the FDA to develop an industry-standard Patient Reported Outcome

Clinverse, Inc. and the Alliance for Clinical Research Excellence and Safety announced today that they have formed a strategic partnership.

New PRO measure being developed in conjunction with the FNIH Biomarkers Consortium

Growing insistence on making healthcare more patient-centered is generating a new level of interest in helping patients to meet the expectations the new orthodoxy is creating.

ERT announced the acquisition of eClinical Insights

Clinverse and ACRES announced a strategic alliance.

Combined Offering Enables Real Time Decision Making in Global Clinical Trials

Here is a summary of what analysts are saying about LabCorp's purchase of Covance.

Drugs that treat central nervous system diseases take more than a year longer to develop and are less than half as likely to obtain marketing approval

Joint Effort to Enable Faster, Safer and Smarter Clinical Trial Reviews for Life Science Industry

OPKO has selected DSG?s eCaseLink integrated suite

EUCROF released proposals on the early publication of clinical trial information, balancing the public's need for transparency and innovators' intellectual property and confidentiality rights.

OPKO Health to build and configure integrated data capture and drug safety systems

Drugs that treat central nervous system diseases take more than a year longer to develop

EUCROF has unveiled proposals on the early publication of clinical trial information.

Medidata and PPD announced they are expanding their partnership around risk-based monitoring.

This position paper has been prepared by the European Contract Research Organisation Federation (EUCROF).

LabCorp and Covance have entered into a definitive agreement

The sharp rise in ongoing clinical research studies is driving demand for greater participation in research by physicians as well as by patients.

So now we know who is to do what on health issues in the new European Commission. Or do we?

Covance shareholders to receive cash and LabCorp shares currently valued at $105.12 per Covance share

We hear it all the time these days: research processes have to undergo transformative changes in order for research organizations to thrive?or even survive.

There's a mounting campaign to encourage biopharmaceutical companies to develop new therapies to treat drug-resistant infections.

Velos recently activated its Investigational Drug System at The University of Texas MD Anderson Cancer Center